Point-of-care Biosensors Market (By Product: Glucose Monitoring, HIV, Hepatitis C, Pregnancy; By Platforms: Microfluidics, Dipsticks, Immunoassays; By Purchase: OTC, Prescription; By Sample: Blood, Urine; By End User: Pharmacy, Hospital, Homecare) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-care Biosensors Market 

5.1. COVID-19 Landscape: Point-of-care Biosensors Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-care Biosensors Market, By Product

8.1. Point-of-care Biosensors Market Revenue and Volume, by Product, 2023-2032

8.1.1. Glucose Monitoring

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. HIV

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Hepatitis C

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Pregnancy

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Point-of-care Biosensors Market, By Platforms

9.1. Point-of-care Biosensors Market Revenue and Volume, by Platforms, 2023-2032

9.1.1. Microfluidics

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Immunoassays

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Point-of-care Biosensors Market, By Purchase 

10.1. Point-of-care Biosensors Market Revenue and Volume, by Purchase, 2023-2032

10.1.1. OTC

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Prescription

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Point-of-care Biosensors Market, By Sample

11.1. Point-of-care Biosensors Market Revenue and Volume, by Sample, 2023-2032

11.1.1. Blood

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Urine

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Point-of-care Biosensors Market, By End User

12.1. Point-of-care Biosensors Market Revenue and Volume, by End User, 2023-2032

12.1.1. Pharmacy

12.1.1.1. Market Revenue and Volume Forecast (2020-2032)

12.1.2. Hospital

12.1.2.1. Market Revenue and Volume Forecast (2020-2032)

12.1.3. Homecare

12.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 13. Global Point-of-care Biosensors Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.1.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.1.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.1.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.1.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.1.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.1.6.5. Market Revenue and Volume Forecast, by End User (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.7.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.1.7.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.1.7.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.1.7.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.4. Market Revenue and Volume Forecast, by Sample (2020-2032) 

13.2.5. Market Revenue and Volume Forecast, by End User (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.7. Market Revenue and Volume Forecast, by Sample (2020-2032) 

13.2.8. Market Revenue and Volume Forecast, by End User (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.9.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.9.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.10. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.11. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.12.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.12.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.12.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.13. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.14.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.2.14.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.2.14.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.2.15. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.9. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.3.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.3.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.3.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.9. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.4.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.4.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.4.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.5.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.5.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.5.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.5.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.5.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.5.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)

13.5.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)

13.5.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)

13.5.8.5. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 14. Company Profiles

14.1. Abaxis

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Abbott Laboratories

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Accubiotech Co, Ltd.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. ACON Laboratories, Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Becton, Dickinson and Company

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Biolytical Laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher Corporation (HemoCue)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Siemens Healthineers

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Meridian Bioscience, Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample